Following the discoveries in glioma and AML, mutations in IDH2 gene were found in multiple types of human tumors, including thyroid carcinomas, cartilaginous tumors, and intrahepatic cholangiocarcinoma [31]. This evidence concerns the gene IDH2 and central nervous system cancer.